Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Medulloblastoma | 21 | 2023 | 679 | 3.160 |
Why?
|
DNA Methylation | 45 | 2024 | 4427 | 1.820 |
Why?
|
Cerebellar Neoplasms | 14 | 2023 | 588 | 1.570 |
Why?
|
Brain Neoplasms | 39 | 2024 | 9101 | 1.110 |
Why?
|
Astrocytoma | 10 | 2023 | 773 | 0.920 |
Why?
|
Isocitrate Dehydrogenase | 12 | 2023 | 950 | 0.690 |
Why?
|
Ependymoma | 7 | 2023 | 326 | 0.660 |
Why?
|
Glioma | 12 | 2024 | 3498 | 0.630 |
Why?
|
Single-Cell Analysis | 8 | 2024 | 2534 | 0.540 |
Why?
|
DNA Copy Number Variations | 12 | 2024 | 2045 | 0.540 |
Why?
|
Glioblastoma | 13 | 2024 | 3458 | 0.530 |
Why?
|
Histones | 12 | 2021 | 2593 | 0.500 |
Why?
|
Gene Expression Regulation, Neoplastic | 16 | 2024 | 8621 | 0.490 |
Why?
|
Central Nervous System Neoplasms | 7 | 2020 | 926 | 0.480 |
Why?
|
Epigenesis, Genetic | 13 | 2024 | 3824 | 0.480 |
Why?
|
Genomics | 9 | 2024 | 5923 | 0.430 |
Why?
|
Disease Susceptibility | 1 | 2019 | 1791 | 0.410 |
Why?
|
Mutation | 33 | 2023 | 30213 | 0.400 |
Why?
|
Chromosomes, Human, Pair 1 | 5 | 2024 | 640 | 0.390 |
Why?
|
Neoplasms, Germ Cell and Embryonal | 4 | 2019 | 497 | 0.380 |
Why?
|
Oligonucleotide Array Sequence Analysis | 4 | 2020 | 3796 | 0.360 |
Why?
|
Neuroectodermal Tumors, Primitive | 3 | 2016 | 136 | 0.340 |
Why?
|
Gene Silencing | 3 | 2021 | 1504 | 0.340 |
Why?
|
DEAD-box RNA Helicases | 6 | 2019 | 385 | 0.320 |
Why?
|
Sequence Analysis, DNA | 6 | 2017 | 4780 | 0.310 |
Why?
|
Ribonuclease III | 3 | 2019 | 271 | 0.280 |
Why?
|
Pinealoma | 2 | 2018 | 52 | 0.270 |
Why?
|
Oncogenes | 5 | 2023 | 1231 | 0.270 |
Why?
|
Neoplasm Proteins | 7 | 2018 | 3601 | 0.260 |
Why?
|
Neoplasms, Neuroepithelial | 2 | 2016 | 43 | 0.260 |
Why?
|
Telomerase | 6 | 2017 | 750 | 0.260 |
Why?
|
Cell Lineage | 5 | 2023 | 2572 | 0.250 |
Why?
|
Receptor, Platelet-Derived Growth Factor alpha | 4 | 2023 | 367 | 0.250 |
Why?
|
CpG Islands | 8 | 2021 | 1208 | 0.250 |
Why?
|
Rhabdoid Tumor | 3 | 2016 | 211 | 0.250 |
Why?
|
Neurilemmoma | 3 | 2016 | 522 | 0.250 |
Why?
|
Sequence Analysis, RNA | 9 | 2020 | 2039 | 0.250 |
Why?
|
Hedgehog Proteins | 4 | 2021 | 771 | 0.250 |
Why?
|
Epigenomics | 6 | 2019 | 959 | 0.220 |
Why?
|
Eye Neoplasms | 2 | 2016 | 305 | 0.220 |
Why?
|
Sulfites | 2 | 2021 | 83 | 0.210 |
Why?
|
Metencephalon | 1 | 2022 | 3 | 0.210 |
Why?
|
Gene Expression Profiling | 17 | 2019 | 9525 | 0.210 |
Why?
|
Brain Stem Neoplasms | 2 | 2016 | 191 | 0.210 |
Why?
|
Transcription Factors | 12 | 2017 | 12150 | 0.200 |
Why?
|
Meningioma | 2 | 2024 | 1221 | 0.200 |
Why?
|
Nuclear Proteins | 9 | 2018 | 5795 | 0.200 |
Why?
|
Child | 38 | 2023 | 80668 | 0.200 |
Why?
|
Meningeal Neoplasms | 2 | 2024 | 1255 | 0.190 |
Why?
|
Burkitt Lymphoma | 2 | 2015 | 338 | 0.190 |
Why?
|
Genome | 3 | 2021 | 1752 | 0.190 |
Why?
|
DNA Modification Methylases | 6 | 2018 | 207 | 0.190 |
Why?
|
Neoplasm Recurrence, Local | 7 | 2024 | 9404 | 0.190 |
Why?
|
Neurofibromatoses | 2 | 2016 | 303 | 0.180 |
Why?
|
Nucleocytoplasmic Transport Proteins | 1 | 2021 | 73 | 0.180 |
Why?
|
In Situ Hybridization, Fluorescence | 4 | 2021 | 2510 | 0.180 |
Why?
|
Wnt Proteins | 3 | 2021 | 722 | 0.180 |
Why?
|
Germinal Center | 2 | 2021 | 379 | 0.180 |
Why?
|
Enhancer Elements, Genetic | 3 | 2019 | 1363 | 0.180 |
Why?
|
Neurons | 6 | 2024 | 9515 | 0.180 |
Why?
|
Neoplasms | 4 | 2024 | 22350 | 0.170 |
Why?
|
Child, Preschool | 22 | 2019 | 42577 | 0.170 |
Why?
|
DNA Repair Enzymes | 6 | 2018 | 342 | 0.170 |
Why?
|
Humans | 91 | 2024 | 766766 | 0.170 |
Why?
|
Promoter Regions, Genetic | 7 | 2017 | 5789 | 0.170 |
Why?
|
Genetic Association Studies | 2 | 2019 | 2746 | 0.160 |
Why?
|
Choroid Plexus Neoplasms | 2 | 2016 | 38 | 0.160 |
Why?
|
Cerebellum | 3 | 2023 | 1520 | 0.160 |
Why?
|
Cell Line, Tumor | 12 | 2024 | 17088 | 0.160 |
Why?
|
High-Throughput Nucleotide Sequencing | 5 | 2021 | 3666 | 0.150 |
Why?
|
Mice | 17 | 2024 | 81889 | 0.150 |
Why?
|
MicroRNAs | 4 | 2019 | 3792 | 0.150 |
Why?
|
Pineal Gland | 2 | 2018 | 158 | 0.150 |
Why?
|
Cell Transformation, Neoplastic | 4 | 2023 | 2839 | 0.150 |
Why?
|
Genome, Human | 6 | 2018 | 4443 | 0.150 |
Why?
|
Ultraviolet Rays | 1 | 2023 | 1101 | 0.150 |
Why?
|
Prognosis | 14 | 2024 | 29948 | 0.150 |
Why?
|
Sarcoma | 3 | 2021 | 1802 | 0.150 |
Why?
|
DNA Mutational Analysis | 5 | 2017 | 4114 | 0.150 |
Why?
|
Kruppel-Like Transcription Factors | 3 | 2017 | 505 | 0.140 |
Why?
|
Infant | 17 | 2019 | 36461 | 0.140 |
Why?
|
Forkhead Transcription Factors | 2 | 2022 | 1627 | 0.140 |
Why?
|
Gene Duplication | 1 | 2018 | 315 | 0.140 |
Why?
|
Tumor Microenvironment | 3 | 2019 | 3944 | 0.140 |
Why?
|
Drug Resistance, Neoplasm | 3 | 2020 | 5329 | 0.140 |
Why?
|
DNA-Binding Proteins | 6 | 2017 | 9611 | 0.130 |
Why?
|
Infratentorial Neoplasms | 1 | 2017 | 99 | 0.130 |
Why?
|
DNA Helicases | 4 | 2014 | 853 | 0.130 |
Why?
|
Neuroectodermal Tumors | 1 | 2016 | 23 | 0.130 |
Why?
|
Papilloma, Choroid Plexus | 1 | 2016 | 9 | 0.130 |
Why?
|
Teratoma | 2 | 2016 | 405 | 0.130 |
Why?
|
Ataxia Telangiectasia | 1 | 2017 | 107 | 0.130 |
Why?
|
Muscle Proteins | 2 | 2018 | 1160 | 0.130 |
Why?
|
Animals | 18 | 2024 | 168930 | 0.130 |
Why?
|
Leukemia, Myeloid, Acute | 2 | 2023 | 3636 | 0.120 |
Why?
|
Genomic Instability | 2 | 2017 | 716 | 0.120 |
Why?
|
Nerve Tissue Proteins | 2 | 2021 | 4400 | 0.120 |
Why?
|
Adolescent | 22 | 2023 | 88904 | 0.120 |
Why?
|
Workflow | 1 | 2020 | 859 | 0.120 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2019 | 614 | 0.120 |
Why?
|
Gene Regulatory Networks | 2 | 2021 | 1751 | 0.120 |
Why?
|
Supratentorial Neoplasms | 1 | 2016 | 156 | 0.120 |
Why?
|
Skin Neoplasms | 3 | 2023 | 5861 | 0.120 |
Why?
|
Genes, p16 | 1 | 2015 | 157 | 0.120 |
Why?
|
Algorithms | 5 | 2024 | 14072 | 0.120 |
Why?
|
Nerve Sheath Neoplasms | 1 | 2016 | 169 | 0.120 |
Why?
|
Lymphoma, B-Cell | 1 | 2021 | 945 | 0.110 |
Why?
|
Oligodendroglia | 1 | 2018 | 539 | 0.110 |
Why?
|
Tumor Suppressor Proteins | 7 | 2018 | 2801 | 0.110 |
Why?
|
Genomic Structural Variation | 1 | 2014 | 80 | 0.110 |
Why?
|
Kaplan-Meier Estimate | 7 | 2019 | 6512 | 0.110 |
Why?
|
Glutamic Acid | 1 | 2019 | 1181 | 0.110 |
Why?
|
Pyrophosphatases | 1 | 2014 | 143 | 0.110 |
Why?
|
Immunohistochemistry | 5 | 2018 | 11061 | 0.110 |
Why?
|
Gene Deletion | 2 | 2018 | 2669 | 0.110 |
Why?
|
Inhibitor of Differentiation Proteins | 1 | 2012 | 17 | 0.110 |
Why?
|
Oligodendroglioma | 1 | 2014 | 274 | 0.100 |
Why?
|
Phosphoric Diester Hydrolases | 1 | 2014 | 205 | 0.100 |
Why?
|
Chordoma | 1 | 2016 | 349 | 0.100 |
Why?
|
Biological Specimen Banks | 1 | 2018 | 787 | 0.100 |
Why?
|
Chromatin | 3 | 2014 | 2977 | 0.100 |
Why?
|
Female | 44 | 2024 | 396520 | 0.100 |
Why?
|
Receptor, trkB | 1 | 2013 | 123 | 0.100 |
Why?
|
Chromosomal Proteins, Non-Histone | 2 | 2016 | 723 | 0.100 |
Why?
|
Xenograft Model Antitumor Assays | 2 | 2018 | 3607 | 0.100 |
Why?
|
Transaminases | 1 | 2013 | 198 | 0.100 |
Why?
|
Combined Modality Therapy | 3 | 2019 | 8540 | 0.100 |
Why?
|
Protein Phosphatase 1 | 1 | 2012 | 135 | 0.100 |
Why?
|
Gene Knockout Techniques | 1 | 2015 | 803 | 0.100 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2013 | 258 | 0.100 |
Why?
|
Dendritic Cells | 1 | 2023 | 2747 | 0.100 |
Why?
|
Soft Tissue Neoplasms | 1 | 2021 | 1163 | 0.100 |
Why?
|
Cell Proliferation | 6 | 2022 | 10445 | 0.100 |
Why?
|
Methylation | 4 | 2016 | 1074 | 0.100 |
Why?
|
Neoplasm Metastasis | 2 | 2019 | 4891 | 0.100 |
Why?
|
Male | 39 | 2024 | 364142 | 0.090 |
Why?
|
Adult | 26 | 2024 | 223307 | 0.090 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2014 | 856 | 0.090 |
Why?
|
Proto-Oncogene Proteins B-raf | 3 | 2018 | 2056 | 0.090 |
Why?
|
GTPase-Activating Proteins | 1 | 2014 | 465 | 0.090 |
Why?
|
Disease-Free Survival | 6 | 2017 | 6850 | 0.090 |
Why?
|
Lymphoma, Follicular | 1 | 2015 | 460 | 0.090 |
Why?
|
RNA Stability | 1 | 2013 | 319 | 0.090 |
Why?
|
Survival Analysis | 6 | 2024 | 10100 | 0.090 |
Why?
|
Amino Acids, Branched-Chain | 1 | 2013 | 267 | 0.090 |
Why?
|
Cell Differentiation | 4 | 2021 | 11651 | 0.090 |
Why?
|
Recurrence | 2 | 2019 | 8507 | 0.090 |
Why?
|
Receptors, G-Protein-Coupled | 2 | 2014 | 1245 | 0.080 |
Why?
|
Software | 1 | 2024 | 4466 | 0.080 |
Why?
|
Gene Library | 1 | 2012 | 1065 | 0.080 |
Why?
|
Skin | 1 | 2023 | 4499 | 0.080 |
Why?
|
Repressor Proteins | 3 | 2016 | 2978 | 0.080 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2021 | 1882 | 0.080 |
Why?
|
Disease Management | 1 | 2019 | 2533 | 0.080 |
Why?
|
Protein Biosynthesis | 1 | 2016 | 2093 | 0.080 |
Why?
|
Chromosomes, Human, Pair 19 | 3 | 2014 | 350 | 0.080 |
Why?
|
Base Sequence | 6 | 2019 | 12415 | 0.080 |
Why?
|
Signal Transduction | 8 | 2021 | 23619 | 0.080 |
Why?
|
Stress, Physiological | 1 | 2016 | 1406 | 0.080 |
Why?
|
Estrogen Receptor alpha | 1 | 2012 | 581 | 0.080 |
Why?
|
Binding Sites | 2 | 2014 | 6012 | 0.080 |
Why?
|
Bone Neoplasms | 1 | 2021 | 2561 | 0.080 |
Why?
|
Germany | 3 | 2016 | 882 | 0.080 |
Why?
|
Tamoxifen | 1 | 2012 | 967 | 0.070 |
Why?
|
Cluster Analysis | 4 | 2017 | 2717 | 0.070 |
Why?
|
Zebrafish Proteins | 1 | 2014 | 1018 | 0.070 |
Why?
|
Disease Progression | 4 | 2019 | 13640 | 0.070 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2017 | 1560 | 0.070 |
Why?
|
Specimen Handling | 1 | 2012 | 706 | 0.070 |
Why?
|
Chromatin Assembly and Disassembly | 1 | 2012 | 630 | 0.070 |
Why?
|
Somatic Hypermutation, Immunoglobulin | 2 | 2021 | 103 | 0.070 |
Why?
|
Neoplasm Staging | 2 | 2019 | 11218 | 0.070 |
Why?
|
Young Adult | 14 | 2018 | 59939 | 0.070 |
Why?
|
Molecular Sequence Data | 6 | 2016 | 17608 | 0.070 |
Why?
|
Genes, Immunoglobulin | 2 | 2021 | 283 | 0.070 |
Why?
|
Middle Aged | 21 | 2024 | 223257 | 0.070 |
Why?
|
Neural Stem Cells | 1 | 2014 | 895 | 0.070 |
Why?
|
Zebrafish | 2 | 2016 | 3035 | 0.070 |
Why?
|
Transcription, Genetic | 3 | 2015 | 7609 | 0.060 |
Why?
|
RNA, Messenger | 3 | 2021 | 12791 | 0.060 |
Why?
|
Proteomics | 1 | 2019 | 3914 | 0.060 |
Why?
|
Genetic Predisposition to Disease | 3 | 2018 | 18075 | 0.060 |
Why?
|
Chromosome Deletion | 2 | 2024 | 1384 | 0.060 |
Why?
|
Proto-Oncogene Proteins | 2 | 2016 | 4522 | 0.060 |
Why?
|
RNA-Binding Proteins | 1 | 2014 | 1884 | 0.060 |
Why?
|
Genes, myc | 2 | 2019 | 391 | 0.060 |
Why?
|
Carcinoma | 1 | 2016 | 2324 | 0.060 |
Why?
|
Neurofibromin 1 | 2 | 2016 | 190 | 0.060 |
Why?
|
Principal Component Analysis | 2 | 2017 | 949 | 0.060 |
Why?
|
Bone Marrow Cells | 2 | 2023 | 2413 | 0.050 |
Why?
|
Chromosomes, Human | 2 | 2017 | 437 | 0.050 |
Why?
|
DNA, Neoplasm | 2 | 2019 | 1741 | 0.050 |
Why?
|
Reproducibility of Results | 5 | 2021 | 20144 | 0.050 |
Why?
|
Age Factors | 2 | 2018 | 18397 | 0.050 |
Why?
|
Chromosomes, Human, Pair 9 | 2 | 2014 | 534 | 0.050 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2013 | 3609 | 0.050 |
Why?
|
Computational Biology | 1 | 2013 | 3564 | 0.050 |
Why?
|
Proto-Oncogene Proteins c-ets | 1 | 2022 | 313 | 0.050 |
Why?
|
Oncogene Proteins, Fusion | 3 | 2015 | 1609 | 0.050 |
Why?
|
Gene Dosage | 2 | 2015 | 1211 | 0.040 |
Why?
|
HEK293 Cells | 3 | 2016 | 4276 | 0.040 |
Why?
|
Adaptor Proteins, Signal Transducing | 3 | 2018 | 2902 | 0.040 |
Why?
|
Receptors, Cell Surface | 3 | 2015 | 2815 | 0.040 |
Why?
|
Histone Code | 1 | 2021 | 160 | 0.040 |
Why?
|
Hep G2 Cells | 1 | 2021 | 378 | 0.040 |
Why?
|
Polymorphism, Single Nucleotide | 5 | 2019 | 16044 | 0.040 |
Why?
|
Oncogene Proteins | 2 | 2014 | 715 | 0.040 |
Why?
|
Protein Processing, Post-Translational | 2 | 2021 | 1964 | 0.040 |
Why?
|
Clone Cells | 1 | 2023 | 1670 | 0.040 |
Why?
|
Cohort Studies | 6 | 2021 | 41710 | 0.040 |
Why?
|
Mice, Inbred NOD | 2 | 2014 | 1838 | 0.040 |
Why?
|
DNA Topoisomerases, Type I | 1 | 2019 | 108 | 0.040 |
Why?
|
K562 Cells | 1 | 2021 | 645 | 0.040 |
Why?
|
Immunoglobulin Class Switching | 1 | 2021 | 289 | 0.040 |
Why?
|
Antigens, CD34 | 1 | 2021 | 656 | 0.040 |
Why?
|
Tumor Suppressor Protein p53 | 3 | 2015 | 2948 | 0.040 |
Why?
|
Aged | 11 | 2024 | 171343 | 0.040 |
Why?
|
Mice, SCID | 2 | 2014 | 2628 | 0.040 |
Why?
|
Chromosome Aberrations | 2 | 2015 | 1776 | 0.040 |
Why?
|
Pons | 1 | 2019 | 239 | 0.040 |
Why?
|
Translocation, Genetic | 2 | 2015 | 1392 | 0.040 |
Why?
|
Organ Specificity | 1 | 2023 | 1966 | 0.040 |
Why?
|
Insulin Receptor Substrate Proteins | 1 | 2020 | 558 | 0.040 |
Why?
|
Orphan Nuclear Receptors | 1 | 2018 | 63 | 0.040 |
Why?
|
beta Catenin | 2 | 2014 | 1048 | 0.040 |
Why?
|
Mitogen-Activated Protein Kinase 7 | 1 | 2018 | 66 | 0.040 |
Why?
|
Poly(ADP-ribose) Polymerases | 1 | 2019 | 428 | 0.040 |
Why?
|
Cell Death | 1 | 2023 | 1676 | 0.040 |
Why?
|
Antineoplastic Agents | 1 | 2020 | 13643 | 0.040 |
Why?
|
Tumor Necrosis Factor Receptor-Associated Peptides and Proteins | 1 | 2017 | 43 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-akt | 2 | 2017 | 2456 | 0.030 |
Why?
|
Membrane Proteins | 1 | 2013 | 7868 | 0.030 |
Why?
|
Apoptosis | 1 | 2012 | 9513 | 0.030 |
Why?
|
Austria | 1 | 2016 | 206 | 0.030 |
Why?
|
Transcriptional Activation | 1 | 2022 | 1749 | 0.030 |
Why?
|
Melanoma | 1 | 2014 | 5700 | 0.030 |
Why?
|
INDEL Mutation | 1 | 2017 | 266 | 0.030 |
Why?
|
Switzerland | 1 | 2016 | 322 | 0.030 |
Why?
|
Neurofibromin 2 | 1 | 2017 | 269 | 0.030 |
Why?
|
Disease Models, Animal | 1 | 2015 | 18330 | 0.030 |
Why?
|
Treatment Outcome | 2 | 2019 | 65273 | 0.030 |
Why?
|
B-Lymphocytes | 2 | 2021 | 4784 | 0.030 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 2018 | 635 | 0.030 |
Why?
|
Epistasis, Genetic | 1 | 2017 | 353 | 0.030 |
Why?
|
HeLa Cells | 1 | 2021 | 3073 | 0.030 |
Why?
|
Lysine | 1 | 2019 | 997 | 0.030 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2018 | 705 | 0.030 |
Why?
|
Cell Cycle | 2 | 2013 | 2926 | 0.030 |
Why?
|
Breast Neoplasms | 2 | 2012 | 21162 | 0.030 |
Why?
|
Aged, 80 and over | 5 | 2018 | 59550 | 0.030 |
Why?
|
Probability | 1 | 2020 | 2476 | 0.030 |
Why?
|
RNA, Neoplasm | 1 | 2017 | 747 | 0.030 |
Why?
|
Synaptophysin | 1 | 2014 | 138 | 0.030 |
Why?
|
Genes, Neoplasm | 1 | 2016 | 369 | 0.030 |
Why?
|
Rhombencephalon | 1 | 2014 | 81 | 0.030 |
Why?
|
Cranial Irradiation | 1 | 2016 | 392 | 0.030 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2018 | 857 | 0.030 |
Why?
|
Sequence Analysis | 1 | 2014 | 240 | 0.030 |
Why?
|
E2F1 Transcription Factor | 1 | 2014 | 182 | 0.030 |
Why?
|
Cell Line | 2 | 2021 | 15563 | 0.030 |
Why?
|
Cytodiagnosis | 1 | 2017 | 450 | 0.030 |
Why?
|
Liposarcoma, Myxoid | 1 | 2013 | 60 | 0.030 |
Why?
|
Homozygote | 1 | 2018 | 1775 | 0.030 |
Why?
|
Genetic Heterogeneity | 1 | 2017 | 735 | 0.030 |
Why?
|
Chromosome Breakpoints | 1 | 2013 | 93 | 0.030 |
Why?
|
RNA, Small Interfering | 2 | 2012 | 3425 | 0.030 |
Why?
|
Genes, Developmental | 1 | 2013 | 38 | 0.030 |
Why?
|
Chromosomes, Human, Pair 22 | 1 | 2014 | 348 | 0.030 |
Why?
|
Dacarbazine | 1 | 2016 | 552 | 0.030 |
Why?
|
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2017 | 384 | 0.030 |
Why?
|
RNA-Induced Silencing Complex | 1 | 2013 | 52 | 0.030 |
Why?
|
Chromosome Disorders | 1 | 2016 | 498 | 0.030 |
Why?
|
Retrospective Studies | 6 | 2018 | 81635 | 0.030 |
Why?
|
NIH 3T3 Cells | 1 | 2014 | 655 | 0.030 |
Why?
|
Cytoskeletal Proteins | 1 | 2018 | 1325 | 0.030 |
Why?
|
Transcription Initiation Site | 1 | 2013 | 190 | 0.030 |
Why?
|
Amino Acid Sequence | 2 | 2016 | 13411 | 0.030 |
Why?
|
Survival Rate | 2 | 2017 | 12825 | 0.030 |
Why?
|
Gene Fusion | 1 | 2015 | 356 | 0.020 |
Why?
|
Antineoplastic Agents, Alkylating | 1 | 2016 | 614 | 0.020 |
Why?
|
Ontario | 1 | 2013 | 404 | 0.020 |
Why?
|
Chromosomes, Human, Pair 6 | 1 | 2013 | 370 | 0.020 |
Why?
|
Chromosomes, Human, Pair 14 | 1 | 2012 | 286 | 0.020 |
Why?
|
Polyploidy | 1 | 2012 | 120 | 0.020 |
Why?
|
Metabolism | 1 | 2013 | 193 | 0.020 |
Why?
|
Genes, Reporter | 1 | 2016 | 1525 | 0.020 |
Why?
|
Phenotype | 3 | 2014 | 16724 | 0.020 |
Why?
|
Co-Repressor Proteins | 1 | 2012 | 190 | 0.020 |
Why?
|
Luciferases | 1 | 2012 | 713 | 0.020 |
Why?
|
Chromosomes, Human, Pair 8 | 1 | 2012 | 451 | 0.020 |
Why?
|
Genes, Dominant | 1 | 2013 | 855 | 0.020 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2018 | 1621 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2016 | 2846 | 0.020 |
Why?
|
Neurofibromatosis 2 | 1 | 2014 | 387 | 0.020 |
Why?
|
Phosphoprotein Phosphatases | 1 | 2012 | 327 | 0.020 |
Why?
|
Neoplasm Transplantation | 1 | 2014 | 2012 | 0.020 |
Why?
|
Diagnostic Errors | 1 | 2017 | 1276 | 0.020 |
Why?
|
Cilia | 1 | 2014 | 498 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2015 | 996 | 0.020 |
Why?
|
Neoplasms, Experimental | 1 | 2015 | 1227 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2017 | 4570 | 0.020 |
Why?
|
T-Box Domain Proteins | 1 | 2012 | 471 | 0.020 |
Why?
|
Diagnosis, Differential | 2 | 2016 | 12985 | 0.020 |
Why?
|
Histone Demethylases | 1 | 2012 | 328 | 0.020 |
Why?
|
PTEN Phosphohydrolase | 1 | 2015 | 1117 | 0.020 |
Why?
|
Prospective Studies | 3 | 2022 | 54871 | 0.020 |
Why?
|
Age Distribution | 1 | 2015 | 2869 | 0.020 |
Why?
|
Radiotherapy | 1 | 2016 | 1497 | 0.020 |
Why?
|
Neoplastic Stem Cells | 1 | 2017 | 1351 | 0.020 |
Why?
|
RNA | 1 | 2019 | 2715 | 0.020 |
Why?
|
Histone-Lysine N-Methyltransferase | 1 | 2013 | 698 | 0.020 |
Why?
|
World Health Organization | 1 | 2015 | 1327 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2015 | 1405 | 0.020 |
Why?
|
Biphenyl Compounds | 1 | 2014 | 1026 | 0.020 |
Why?
|
Bone Marrow | 1 | 2019 | 2926 | 0.020 |
Why?
|
Internet | 1 | 2021 | 3113 | 0.020 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2013 | 1168 | 0.020 |
Why?
|
Microglia | 1 | 2017 | 1370 | 0.020 |
Why?
|
DNA, Complementary | 1 | 2011 | 1989 | 0.020 |
Why?
|
DNA Repair | 1 | 2017 | 2050 | 0.020 |
Why?
|
Fibroblast Growth Factors | 1 | 2013 | 871 | 0.020 |
Why?
|
Molecular Chaperones | 1 | 2012 | 760 | 0.020 |
Why?
|
Mice, Nude | 1 | 2013 | 3616 | 0.020 |
Why?
|
Embryonic Stem Cells | 1 | 2014 | 1243 | 0.020 |
Why?
|
Trans-Activators | 1 | 2016 | 2855 | 0.020 |
Why?
|
Receptors, Progesterone | 1 | 2011 | 1159 | 0.020 |
Why?
|
MAP Kinase Signaling System | 1 | 2013 | 1491 | 0.020 |
Why?
|
Glycoproteins | 1 | 2014 | 2201 | 0.020 |
Why?
|
Phosphoproteins | 1 | 2015 | 2448 | 0.020 |
Why?
|
Biopsy | 1 | 2018 | 6779 | 0.020 |
Why?
|
Age of Onset | 1 | 2013 | 3342 | 0.020 |
Why?
|
Molecular Targeted Therapy | 1 | 2017 | 2823 | 0.020 |
Why?
|
Genome-Wide Association Study | 2 | 2017 | 12806 | 0.020 |
Why?
|
Telomere | 1 | 2012 | 943 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2021 | 14652 | 0.020 |
Why?
|
Protein Conformation | 1 | 2013 | 3947 | 0.020 |
Why?
|
Blotting, Western | 1 | 2012 | 5022 | 0.020 |
Why?
|
Tumor Cells, Cultured | 1 | 2012 | 6104 | 0.020 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2014 | 2881 | 0.010 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2012 | 1536 | 0.010 |
Why?
|
Genetic Loci | 1 | 2013 | 2630 | 0.010 |
Why?
|
Chromosome Mapping | 1 | 2012 | 4619 | 0.010 |
Why?
|
Genotype | 1 | 2019 | 13036 | 0.010 |
Why?
|
Mutation, Missense | 1 | 2013 | 2590 | 0.010 |
Why?
|
Carrier Proteins | 1 | 2017 | 4924 | 0.010 |
Why?
|
RNA Interference | 1 | 2012 | 2827 | 0.010 |
Why?
|
Carcinoma, Ductal, Breast | 1 | 2011 | 1097 | 0.010 |
Why?
|
Pediatrics | 1 | 2018 | 3614 | 0.010 |
Why?
|
Antigens, CD | 1 | 2014 | 4032 | 0.010 |
Why?
|
Gene Expression | 1 | 2016 | 7585 | 0.010 |
Why?
|
Models, Molecular | 1 | 2013 | 5386 | 0.010 |
Why?
|
Neoplasm Invasiveness | 1 | 2011 | 3609 | 0.010 |
Why?
|
Receptors, Estrogen | 1 | 2011 | 2251 | 0.010 |
Why?
|
Pyridines | 1 | 2014 | 2888 | 0.010 |
Why?
|
Macrophages | 1 | 2017 | 5783 | 0.010 |
Why?
|
Risk | 1 | 2014 | 9602 | 0.010 |
Why?
|
Peptides | 1 | 2014 | 4344 | 0.010 |
Why?
|
Protein Binding | 1 | 2013 | 9320 | 0.010 |
Why?
|
Brain | 2 | 2019 | 27159 | 0.010 |
Why?
|
Receptor, erbB-2 | 1 | 2011 | 2597 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2013 | 12064 | 0.010 |
Why?
|
Risk Factors | 2 | 2016 | 74881 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2014 | 14471 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2013 | 12534 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2016 | 22248 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2013 | 18984 | 0.010 |
Why?
|
Models, Biological | 1 | 2013 | 9461 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2016 | 11872 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2013 | 11920 | 0.010 |
Why?
|
Risk Assessment | 1 | 2016 | 24295 | 0.010 |
Why?
|
Aging | 1 | 2012 | 8731 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2014 | 39309 | 0.010 |
Why?
|
Time Factors | 1 | 2013 | 40149 | 0.010 |
Why?
|